Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3HMK

Crystal Structure of Serine Racemase

Summary for 3HMK
Entry DOI10.2210/pdb3hmk/pdb
Related1v71 1wtc 3FKP 3fda
DescriptorSerine racemase, MANGANESE (II) ION, PYRIDOXAL-5'-PHOSPHATE, ... (4 entities in total)
Functional Keywordsserine racemase, d-serine, pyridoxal phosphate, plp, nmda glutamate receptor, schizophrenia, isomerase
Biological sourceRattus norvegicus (rat)
Total number of polymer chains2
Total formula weight73763.57
Authors
Smith, M.A.,Barker, J.,Mack, V.,Ebneth, A.,Felicetti, B.,Woods, M. (deposition date: 2009-05-29, release date: 2010-01-26, Last modification date: 2023-11-01)
Primary citationSmith, M.A.,Mack, V.,Ebneth, A.,Moraes, I.,Felicetti, B.,Wood, M.,Schonfeld, D.,Mather, O.,Cesura, A.,Barker, J.
The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding.
J.Biol.Chem., 285:12873-12881, 2010
Cited by
PubMed Abstract: Serine racemase is responsible for the synthesis of D-serine, an endogenous co-agonist for N-methyl-D-aspartate receptor-type glutamate receptors (NMDARs). This pyridoxal 5'-phosphate-dependent enzyme is involved both in the reversible conversion of L- to D-serine and serine catabolism by alpha,beta-elimination of water, thereby regulating D-serine levels. Because D-serine affects NMDAR signaling throughout the brain, serine racemase is a promising target for the treatment of disorders related to NMDAR dysfunction. To provide a molecular basis for rational drug design the x-ray crystal structures of human and rat serine racemase were determined at 1.5- and 2.1-A resolution, respectively, and in the presence and absence of the orthosteric inhibitor malonate. The structures revealed a fold typical of beta-family pyridoxal 5'-phosphate enzymes, with both a large domain and a flexible small domain associated into a symmetric dimer, and indicated a ligand-induced rearrangement of the small domain that organizes the active site for specific turnover of the substrate.
PubMed: 20106978
DOI: 10.1074/jbc.M109.050062
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon